Zhejiang XiaSha Precision Manufacturing (001306)
Search documents
夏厦精密:12月30日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-12-30 11:15
每经头条(nbdtoutiao)——2025十大财经新闻出炉!护航、酣战、变局、狂飙分别指向哪些大事件? (记者 王瀚黎) 每经AI快讯,夏厦精密12月30日晚间发布公告称,公司第二届董事会第十八次会议于2025年12月30日 在公司会议室以现场的方式召开。会议审议了《关于募投项目结项并将节余募集资金永久补充流动资金 的议案》等文件。 ...
夏厦精密:拟将募投项目结项,3575.88万元节余资金拟用于补充流动资金
2 1 Shi Ji Jing Ji Bao Dao· 2025-12-30 10:15
南财智讯12月30日电,夏厦精密公告,公司于2025年12月30日召开第二届董事会第十八次会议,审议通 过了《关于募投项目结项并将节余募集资金永久补充流动资金的议案》。鉴于公司首次公开发行股票募 集资金投资项目"年产30万套新能源汽车驱动减速机构项目"、"年产40万套新能源汽车三合一变速器技 术改造项目"、"年产7.2万套工业机器人新结构减速器技术改造项目"、"夏厦精密研发中心项目"、"补充 流动资金及偿还银行贷款"均已达到预定可使用状态,公司拟对募投项目进行结项。截至2025年12月25 日,募投项目节余募集资金3575.88万元(包含利息收入,实际金额以资金转出当日专户余额为准), 拟永久补充流动资金。在资金全部转出后,公司将注销上述募投项目所涉的募集资金专项账户。 ...
夏厦精密(001306) - 第二届董事会第十八次会议决议公告
2025-12-30 10:15
证券代码:001306 证券简称:夏厦精密 公告编号:2025-066 浙江夏厦精密制造股份有限公司 第二届董事会第十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 公司本次将募投项目结项并将节余募集资金永久补充流动资金,有利于提高 募集资金使用效率,符合全体股东利益,不存在变相改变募集资金投向和损害股 东利益的情况,本次事项审议程序符合相关法律、法规及规范性文件的要求及公 司的有关规定。由于本次节余募集资金金额低于募集资金净额的 10%,本议案无 需提交股东会审批。 公司审计委员会审议通过了此议案,保荐机构对此出具了明确同意的核查意 见。 具体内容详见公司同日披露于巨潮资讯网(http://www.cninfo.com.cn)的 《关于募投项目结项并将节余募集资金永久补充流动资金的公告》(公告编号: 2025-067)、《财通证券股份有限公司关于浙江夏厦精密制造股份有限公司募投 项目结项并将节余募集资金永久补充流动资金的核查意见》。 表决结果:7 票同意,0 票反对,0 票弃权。 三、备查文件 一、董事会会议召开情况 浙江夏厦精密制造股份有 ...
夏厦精密:募投项目结项,3575.88万元节余资金补流
Xin Lang Cai Jing· 2025-12-30 10:14
夏厦精密公告称,公司首次公开发行股票的5个募投项目已达预定可使用状态,拟结项并将节余募集资 金3575.88万元(含利息收入,以转出当日专户余额为准)永久补充流动资金。截至2025年12月25日, 募投项目累计投入72364.15万元,占计划投资的96.49%;募集资金专户余额3575.88万元。节余原因包 括成本管控、利息收入和尾款未付。该事项已获董事会审计委员会和董事会通过,因节余资金未超净额 10%,无需股东会审议,保荐人无异议。资金转出后将注销专项账户。 ...
夏厦精密(001306) - 财通证券股份有限公司关于浙江夏厦精密制造股份有限公司募投项目结项并将节余募集资金永久补充流动资金的核查意见
2025-12-30 10:04
财通证券股份有限公司 关于浙江夏厦精密制造股份有限公司 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意浙江夏厦精密制造股份有限公司首 次公开发行股票注册的批复》(证监许可〔2023〕1892 号),公司获准向社会公 开发行人民币普通股(A 股)股票 15,500,000 股,每股面值 1 元,每股发行价格 为人民币 53.63 元,截至 2023 年 11 月 13 日止,公司实际已向社会公开发行人民 币普通股(A 股)股票 15,500,000 股,应募集资金总额 831,265,000.00 元,减除发 行费用(不含增值税)人民币 81,308,502.06 元后,募集资金净额为 749,956,497.94 元。 上述募集资金已于 2023 年 11 月 13 日全部到位,天健会计师事务所(特殊普 通合伙)进行审验,并出具天健验〔2023〕600 号《验资报告》。 公司已将募集资金存放于本次发行开立的募集资金专项账户,并与保荐人、 存放募集资金的商业银行签署募集资金三方监管协议,对募集资金的存放和使用 进行专户管理。 二、募投项目基本情况 按照《浙江夏厦精密制造股份有限公司首次公开发行股票并 ...
夏厦精密(001306) - 关于募投项目结项并将节余募集资金永久补充流动资金的公告
2025-12-30 10:01
证券代码:001306 证券简称:夏厦精密 公告编号:2025-067 浙江夏厦精密制造股份有限公司 关于募投项目结项并将节余募集资金永久补充流动资金的公告 因本次永久补流的节余募集资金未超过募投项目募集资金净额的 10%,根据 《上市公司募集资金监管规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》及公司《募集资金管理制度》等规定,本事项无 需提交股东会审议。 现将有关情况公告如下: 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意浙江夏厦精密制造股份有限公司首 次公开发行股票注册的批复》(证监许可〔2023〕1892 号),公司获准向社会 公开发行人民币普通股(A 股)股票 15,500,000 股,每股面值 1 元,每股发行价 格为人民币 53.63 元,截至 2023 年 11 月 13 日止,公司实际已向社会公开发行 人民币普通股(A 股)股票 15,500,000 股,应募集资金总额 831,265,000.00 元, 减除发行费用(不含增值税)人民币 81,308,502.06 元后,募集资金净额为 749,956,497.94 元。 上述募集资金已于 20 ...
“ 汽车人,变形出发!”——浙江汽配企业转型 布局人形机器人样本调查
Zhong Guo Zheng Quan Bao· 2025-12-28 23:56
Core Insights - The automotive parts industry in Zhejiang is collectively transforming towards humanoid robotics, viewing it as a significant growth opportunity following the success of electric vehicles and intelligent driving [2][3][7] - The market for humanoid robots is projected to grow substantially, with an expected sales volume of 12,400 units and a market size of 6.339 billion yuan by 2025, and further growth anticipated by 2035 [3][4] Group 1: Industry Transformation - Zhejiang's automotive parts companies are rapidly entering the humanoid robotics sector, with over 100 related companies and more than 40 listed on the A-share market [2][3] - Companies like Junsheng Electronics have upgraded their strategies to "Automotive + Robotics Tier 1," marking the beginning of a new growth phase [2][3] - The collective shift is characterized by strategic partnerships, product launches, and international market expansion [2][3] Group 2: Market Potential - The humanoid robot market is seen as a "potential stock" by Zhejiang automotive parts companies, with a strong belief in its future profitability [3][4] - The commercialization of humanoid robots is accelerating, with significant orders and deliveries reported in 2025 [3][4] Group 3: Cost Reduction and Localization - The rise in domestic production of core components for humanoid robots is driving down costs, with examples showing a 25% reduction in the cost of certain models compared to 2024 [5][6] - Companies are leveraging existing supply chains and production capabilities to reduce investment costs and enhance equipment utilization [6][7] Group 4: Technological Synergy - The transition to humanoid robotics is facilitated by the technological similarities between automotive parts and robotics, allowing for seamless integration and reduced R&D costs [7][8] - The existing expertise in sensors, motors, and mechanical transmission systems within the automotive sector is being effectively transferred to the humanoid robotics field [7][8] Group 5: Collaborative Ecosystem - The high overlap of customers between the automotive and humanoid robotics sectors enhances market entry opportunities for companies [8] - The collaborative nature of the supply chain is enabling companies to tap into existing channels for humanoid robot component procurement [8]
【盘中播报】131只个股突破年线
Zheng Quan Shi Bao Wang· 2025-12-25 06:34
Group 1 - The Shanghai Composite Index closed at 3958.00 points, above the annual line, with a change of 0.43% [1] - The total trading volume of A-shares reached 1552.045 billion yuan [1] - A total of 131 A-shares have surpassed the annual line, with notable stocks including Xusheng Group, Chongqing Port, and *ST Zhisheng showing significant deviation rates of 8.27%, 8.15%, and 4.95% respectively [1] Group 2 - Stocks with the highest deviation rates from the annual line include: - Xusheng Group (10.01% increase, 8.74% turnover rate, latest price 15.38 yuan, deviation rate 8.27%) - Chongqing Port (10.02% increase, 2.26% turnover rate, latest price 5.82 yuan, deviation rate 8.15%) - *ST Zhisheng (4.98% increase, 3.86% turnover rate, latest price 11.60 yuan, deviation rate 4.95%) [1] - Other stocks with smaller deviation rates that have just crossed the annual line include Hu塑股份, Hu鑫股份, and Heng申新材 [1]
夏厦精密12月18日获融资买入465.90万元,融资余额8272.29万元
Xin Lang Zheng Quan· 2025-12-19 01:27
Core Viewpoint - The financial performance of Zhejiang Xiasha Precision Manufacturing Co., Ltd. shows mixed results, with revenue growth but a significant decline in net profit, indicating potential challenges ahead for the company [2]. Group 1: Financial Performance - As of September 30, 2025, Xiasha Precision achieved operating revenue of 575 million yuan, representing a year-on-year increase of 24.66% [2]. - The net profit attributable to shareholders was 25.29 million yuan, reflecting a year-on-year decrease of 47.02% [2]. - Cumulative cash dividends since the company's A-share listing amount to 60.14 million yuan [3]. Group 2: Shareholder and Market Activity - As of December 18, 2023, the company experienced a financing net purchase of 278,800 yuan, with a total financing and securities balance of 82.97 million yuan [1]. - The financing balance of 82.72 million yuan accounts for 6.82% of the circulating market value, which is below the 20th percentile level over the past year, indicating a low financing position [1]. - The number of shareholders decreased by 26.08% to 9,167, while the average circulating shares per person increased by 35.28% to 1,690 shares [2]. Group 3: Major Shareholders - The largest circulating shareholder is Yongying Advanced Manufacturing Smart Selection Mixed Fund A, holding 2.1255 million shares as a new shareholder [3]. - Ping An Advanced Manufacturing Theme Stock Fund A increased its holdings by 504,400 shares, now holding 935,700 shares [3]. - Other notable shareholders include Huaxia CSI Robot ETF and Debang High-end Equipment Mixed Fund A, both of which have increased their holdings [3].
财通证券股份有限公司关于浙江夏厦精密制造股份有限公司2025年度持续督导培训情况报告
Shang Hai Zheng Quan Bao· 2025-12-12 20:37
Group 1 - The core viewpoint of the article is that the training conducted by the sponsor, Caitong Securities, for Zhejiang Xiasha Precision Manufacturing Co., Ltd. is aimed at enhancing the understanding of legal responsibilities and obligations among the company's directors and senior management [1][2] Group 2 - The training took place on December 8, 2025, and focused on the management and use of raised funds, significant operational changes, and protecting the interests of the listed company [1] - The training included discussions on recent penalty cases and explained relevant regulations and rules issued by the China Securities Regulatory Commission and the Shenzhen Stock Exchange [1] - The training successfully improved the understanding of laws and regulations among the company's directors and senior management, clarifying their rights, obligations, and legal responsibilities [2]